Related Experiment Video
Updated: May 31, 2026

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation
Published on: May 31, 2016
Inhibitors of vascular calcification as potential therapeutic targets
Raja Rezg1, Fellype C Barreto, Daniela V Barreto
1INSERM ERI-12 (EA 4292), Amiens, France.
Insights
Vascular calcification, common with aging, increases cardiovascular risks. Inhibitory factors in the arterial wall offer potential therapeutic targets for this condition.
Area of Science:
- Cardiovascular Science
- Nephrology
- Endocrinology
Background:
- Vascular calcification is a prevalent condition, increasing with age and contributing to cardiovascular morbidity and mortality.
- It is frequently observed in advanced atherosclerosis, and its severity is exacerbated by diabetes mellitus and chronic kidney disease (CKD).
- Vascular calcification involves both passive and active calcium phosphate deposition in the arterial wall, counteracted by inhibitory factors.
Purpose of the Study:
- To review the roles of vascular calcification inhibitors.
- To identify potential therapeutic targets for vascular calcification.
Main Methods:
- Literature review of vascular calcification inhibitors.
- Discussion of passive and active calcification processes.
- Analysis of inhibitory proteins and nonpeptidic factors.
Main Results:
- Vascular calcification is a complex process involving calcium phosphate deposition.
- Inhibitory proteins and nonpeptidic factors play a role in preventing calcification.
- Several inhibitors are identified as potential therapeutic targets.
Conclusions:
- Understanding vascular calcification inhibitors is crucial for developing new treatments.
- Targeting these inhibitors may offer a novel therapeutic strategy for managing vascular calcification.
- Further research into these inhibitors could mitigate cardiovascular risks associated with vascular calcification.
Abstract:
Vascular calcification is frequent in the general population. Its incidence increases with age. It contributes to cardiovascular morbidity and mortality in patients with advanced atherosclerosis, in the presence or absence of diabetes mellitus and chronic kidney disease (CKD). Both diabetes and CKD aggravate its degree of severity and accelerate its progression. Vascular calcification is the result of both passive and active processes of calcium phosphate deposition in the arterial wall. These processes are more or less successfully opposed by inhibitory proteins and nonpeptidic factors. In the present overview we discuss the roles of several among these vascular calcification inhibitors which represent potential therapeutic targets.
Related Concept Videos
Antihypertensive Drugs: Action of Calcium Channel Blockers
Antihypertensive Drugs: Vasodilators
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
